Beaumont Financial Partners, LLC Bristol Myers Squibb CO Transaction History

Beaumont Financial Partners, LLC

$1.04 Billion
Q3 2022

A detailed history of Beaumont Financial Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 25,089 shares of BMY stock, worth $1.36 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

25,089

Previous 25,309 0.87%

Holding current value

$1.36 Million

Previous $1.95 Million 8.47%

% of portfolio

0.17%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $28 - $16,904	-220 Reduced 0.87%	25,089 $1.78 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $66,229 - $72,941	-912 Reduced 3.48%	25,309 $1.95 Million
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $88,654 - $106,304	-1,442 Reduced 5.21%	26,221 $1.92 Million
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $94,925 - $110,660	-1,770 Reduced 6.01%	27,663 $1.73 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $19,407 - $22,733	-328 Reduced 1.1%	29,433 $1.74 Million
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $4,395 - $4,786	71 Added 0.24%	29,761 $1.99 Million
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $11,630 - $13,081	-196 Reduced 0.66%	29,690 $1.87 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $136,786 - $155,003	-2,369 Reduced 7.34%	29,886 $1.85 Million
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $58,406 - $64,721	-1,017 Reduced 3.06%	32,255 $1.95 Million
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $54,984 - $64,282	-1,003 Reduced 2.93%	33,272 $1.96 Million
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $47,792 - $69,452	-1,030 Reduced 2.92%	34,275 $1.91 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $757,587 - $988,205	15,395 Added 77.32%	35,305 $2.27 Million
Q3 2019 Nov 06, 2019	BUY	$42.77 - $50.71 $342,331 - $405,882	8,004 Added 67.23%	19,910 $1.01 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $71,838 - $79,437	1,610 Added 15.64%	11,906 $540,000
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $95,519 - $113,894	-2,117 Reduced 17.05%	10,296 $491,000
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $8,533 - $11,065	-175 Reduced 1.39%	12,413 $645,000
Q3 2018 Nov 02, 2018	BUY	$55.19 - $62.25 $496 - $560	9 Added 0.07%	12,588 $781,000
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $22,132 - $27,585	-438 Reduced 3.36%	12,579 $696,000
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $245,252 - $282,335	4,093 Added 45.87%	13,017 $823,000
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $10,429 - $11,370	-174 Reduced 1.91%	8,924 $547,000
Q3 2017 Oct 31, 2017	SELL	$55.23 - $63.74 $117,805 - $135,957	-2,133 Reduced 18.99%	9,098 $580,000
Q2 2017 Aug 11, 2017	BUY	N/A	11,231	11,231 $626,000

Others Institutions Holding BMY

# of Institutions

2,404

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.

Account

Beaumont Financial Partners, LLC Bristol Myers Squibb CO Transaction History